Fidelity Funds - Global Health Care Fund A-Acc-EUR
Fidelity Funds (SICAV domiciled in Luxembourg)
Key Information
Legal Documents
Performance
Analysis

Fund Profile

Category: SICAV

Aims to provide long-term capital growth with the level of income expected to be low. At least 70% invested in the shares of companies throughout the world that are involved in the design, manufacture, or sale of products and services used in health care, medicine or biotechnology. Has the freedom to invest outside the fund's principal geographies, market sectors, industries or asset classes. May invest in assets directly or achieve exposure indirectly through other eligible means including derivatives. Can use derivatives with the aim of risk or cost reduction or to generate additional capital or income, including for investment purposes, in line with the fund’s risk profile. The fund has discretion in its choices of investments within its objectives and policies. Income is accumulated in the share price. Shares can usually be bought and sold each business day of the fund. This fund may not be appropriate for investors who plan to sell their shares in the fund within 5 years. Investment in the fund should be regarded as a long-term investment.

Morningstar Rating
More information about the calculation of the Morningstar Ratings
Risk and reward profile
6
Lower Risk
Possible Lower
Returns
Higher Risk
Possible Higher
Returns
Key Information
Closing Price 27/11/202033.44
Morningstar categorySector Equity Healthcare
CurrencyEUR
Distribution statusAccumulating
ISINLU0261952419
Inception Date25/09/2006
Minimum initial amount100.00 EUR
Fees And Charges
Entry feeNone
Custody feeNone
Exit feeNone
Ongoing charge1.91% of which 0.60% is paid to MeDirect
Fund management company
AddressFidelity (FIL Inv Mgmt (Lux) S.A.) 2a, rue Albert Borschette Luxembourg L-1246 Luxembourg
Manager NameAlex Gold
Manager Start Date01/07/2019
Websitewww.fidelity-international.com
Total Net Assets (mil)1,140.58 EUR (31/10/2020)
UCITSYes
AdministratorFIL Investment Management (Lux) S.A

Documents

Prospectus
en 01/09/2020
Annual Report
en 30/04/2020
Semi Annual Report
en 31/10/2019
Morningstar Report
30/11/2020

Performance

Historical returns are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Entry fees, purchase charges, custody fees, exit fees, sale charges and taxes are not included in the calculation of past performance. Ongoing charges (including management fees, administrative fees and other costs) have been taken in to account, as they are already included in the price/NAV of the fund.
Annualised performance in EUR
PeriodAnnualised returnDate
1 year2.17%27/11/2020
3 years12.11%27/11/2020
5 years5.48%27/11/2020
10 years12.56%27/11/2020
Since launch8.89%27/11/2020
Cumulative performance in EUR
Performance
YTD 01/01/20201.09
1 month0.66
3 months1.00
6 months2.45
Quarterly Returns
Q 1Q 2Q 3Q 4
2020-11.22%9.77%2.95%-
201911.76%0.96%3.74%8.28%
2018-3.61%11.58%10.06%-7.51%
20177.35%-0.73%-3.49%1.45%
2016-12.22%5.86%-1.01%-2.43%
Dividend

Asset Allocation
% Long% Short% Net Assets
Stock98.44%0.00%98.44%
Bond0.01%0.00%0.01%
Cash1.61%0.06%1.54%
Other0.00%0.00%0.00%
Return/Risk Analysis
Risk Measurement1 Year3 Years5 Years
Standard Deviation
18.1414.1613.29
Sharpe Ratio
0.550.660.47
Sortino Ratio
0.981.080.70
Positive Months6.0023.0034.00
Negative Months5.0012.0025.00
Worst Month-7.11-7.25-8.60
World Regions
Region%
United States67.78
Europe - ex Euro12.81
Eurozone5.29
United Kingdom3.97
Japan3.34
Australasia3.25
Asia - Emerging2.00
Stock Sector Weighting
Sector% of Equity
Healthcare98.05
Top 10 Holdings
HoldingSectorCountry% of Assets
Thermo Fisher Scientific Inc HealthcareUnited States6.42
UnitedHealth Group Inc HealthcareUnited States5.51
Roche Holding AG Dividend Right Cert. HealthcareSwitzerland4.33
Humana Inc HealthcareUnited States3.50
AbbVie Inc HealthcareUnited States3.44
Stryker Corp HealthcareUnited States3.35
Zimmer Biomet Holdings Inc HealthcareUnited States3.30
CSL Ltd HealthcareAustralia3.25
Baxter International Inc HealthcareUnited States3.23
IQVIA Holdings Inc HealthcareUnited States2.98
Classification of Morningstar Category
Ranking1 Year2 Years3 Years5 Years
Top 25%
Category above the average
Category below the average
Bottom 25%
Morningstar Style Box
Equity Style
Large
Size
Mid
Small
Value
Blend
Growth
Style
33.44
Closing Price
All key information and documents must be reviewed before being able to Invest.